Deciphera Pharmaceuticals, a commercial biopharmaceutical company, is decoding cancer at the molecular level by leveraging its proprietary platform to develop a diverse pipeline of drug candidates designed to improve outcomes for patients. The Company is excited to announce its first FDA-approved medicine, visit our product website at qinlockhcp.com for more information.
Qinlock (ripretinib) Prescribing Information »
Featured Content
